SCHEMBL23601709

SCHEMBL23601709

CC(C)(CCc1cc(F)cc(N(CC(F)F)c2nc3nncn3c3c(F)cc(F)cc23)c1)C(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23601511 0.87 CRY1 (0.30)
SCHEMBL23601868 0.84
SCHEMBL23601466 0.83 SMN1; SMN2 (0.31)
SCHEMBL23601893 0.83
SCHEMBL23601457 0.82 KDM4E (0.30)
SCHEMBL23577929 0.80
SCHEMBL29909469 0.80
SCHEMBL23601710 0.76
SCHEMBL23601436 0.75 CRY1 (0.31)
SCHEMBL23601852 0.75 SMN1; SMN2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021130638-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES, INC. (JP) 2021-07-01 WO disclosed